Payment overview · 2025
General Payments
$106.17
6 reported records · 6 companies
Healthcare provider profile · identity verified
Jalal Joudeh, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · DEQUINCY, LA · NPI 1861425324
Verified facts
What the public records show
CMS Open Payments records show Jalal Joudeh, M.D. received $106.17 in general payments during 2025 across 6 reported records.
Insulet Corporation accounted for 19.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 170 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 131 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 39 claims for Trulicity by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Insulet Corporation | Unresolved — no canonical attribution shown | $20.62 | 19.4% | 1 | 2025 |
| VERTEX PHARMACEUTICALS INCORPORATED | Unresolved — no canonical attribution shown | $19.79 | 18.6% | 1 | 2025 |
| Xeris Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $17.86 | 16.8% | 1 | 2025 |
| Verona Pharma, Inc. | Unresolved — no canonical attribution shown | $16.56 | 15.6% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $16.50 | 15.5% | 1 | 2025 |
| Averitas Pharma Inc. | Unresolved — no canonical attribution shown | $14.84 | 14.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $106.17 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Omnipod Normalized: omnipod |
Device | Insulet Corporation | $20.62 | 1 | 2025 |
Source payment records
|
|||||
| JOURNAVX Normalized: journavx |
Drug | VERTEX PHARMACEUTICALS INCORPORATED | $19.79 | 1 | 2025 |
Source payment records
|
|||||
| GVOKE HYPOPEN Normalized: gvoke hypopen |
Drug | Xeris Pharmaceuticals, Inc. | $17.86 | 1 | 2025 |
Source payment records
|
|||||
| Ohtuvayre Normalized: ohtuvayre |
Drug | Verona Pharma, Inc. | $16.56 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $16.50 | 1 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $16.50 | 1 | 2025 |
Source payment records
|
|||||
| QUTENZA Normalized: qutenza |
Drug | Averitas Pharma Inc. | $14.84 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 131 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
170 | 32 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
131 | 20 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
39 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 807 | 154 |
| Levothyroxine Sodium | Levothyroxine Sodium | 789 | 134 |
| Atorvastatin Calcium | Atorvastatin Calcium | 773 | 141 |
| Pantoprazole Sodium | Pantoprazole Sodium | 760 | 128 |
| Gabapentin | Gabapentin | 722 | 123 |
| Furosemide | Furosemide | 591 | 122 |
| Losartan Potassium | Losartan Potassium | 575 | 112 |
| Metformin Hcl | Metformin Hcl | 528 | 101 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 441 | 93 |
| Lisinopril | Lisinopril | 413 | 79 |
| Potassium Chloride | Potassium Chloride | 407 | 83 |
| Tamsulosin Hcl | Tamsulosin Hcl | 341 | 61 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 312 | 104 |
| Metoprolol Tartrate | Metoprolol Tartrate | 309 | 60 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 274 | 52 |
| Omeprazole | Omeprazole | 273 | 52 |
| Januvia | Sitagliptin Phosphate | 269 | 36 |
| Metoprolol Succinate | Metoprolol Succinate | 265 | 53 |
| Alprazolam | Alprazolam | 264 | 40 |
| Eliquis | Apixaban | 252 | 38 |
| Clopidogrel | Clopidogrel Bisulfate | 248 | 50 |
| Trazodone Hcl | Trazodone Hcl | 238 | 48 |
| Carvedilol | Carvedilol | 226 | 37 |
| Duloxetine Hcl | Duloxetine Hcl | 220 | 34 |
| Sertraline Hcl | Sertraline Hcl | 209 | 36 |
| Hydrochlorothiazide | Hydrochlorothiazide | 206 | 50 |
| Buspirone Hcl | Buspirone Hcl | 200 | 37 |
| Simvastatin | Simvastatin | 200 | 40 |
| Glimepiride | Glimepiride | 199 | 42 |
| Divalproex Sodium | Divalproex Sodium | 188 | 19 |
| Escitalopram Oxalate | Escitalopram Oxalate | 184 | 26 |
| Tramadol Hcl | Tramadol Hcl | 182 | 43 |
| Memantine Hcl | Memantine Hcl | 176 | 24 |
| Jardiance | Empagliflozin | 170 | 32 |
| Montelukast Sodium | Montelukast Sodium | 169 | 36 |
| Meloxicam | Meloxicam | 167 | 42 |
| Clonidine Hcl | Clonidine Hcl | 164 | 28 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 161 | 32 |
| Quetiapine Fumarate | Quetiapine Fumarate | 161 | 23 |
| Allopurinol | Allopurinol | 156 | 27 |
| Pravastatin Sodium | Pravastatin Sodium | 152 | 31 |
| Mirtazapine | Mirtazapine | 145 | 26 |
| Ezetimibe | Ezetimibe | 142 | 28 |
| Nifedipine Er | Nifedipine | 134 | 33 |
| Mounjaro | Tirzepatide | 131 | 20 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 130 | 21 |
| Levetiracetam | Levetiracetam | 130 | 15 |
| Spironolactone | Spironolactone | 130 | 30 |
| Fluticasone Propionate | Fluticasone Propionate | 129 | 44 |
| Famotidine | Famotidine | 124 | 22 |
| Fenofibrate | Fenofibrate | 116 | 17 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 115 | 84 |
| Clonazepam | Clonazepam | 111 | 21 |
| Tizanidine Hcl | Tizanidine Hcl | 104 | 24 |
| Atenolol | Atenolol | 98 | 20 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 97 | 20 |
| Donepezil Hcl | Donepezil Hcl | 96 | 13 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 96 | 19 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 95 | 17 |
| Prednisone | Prednisone | 94 | 49 |
| Pregabalin | Pregabalin | 92 | 18 |
| Ketoconazole | Ketoconazole | 91 | 24 |
| Pioglitazone Hcl | Pioglitazone Hcl | 89 | 14 |
| Amitriptyline Hcl | Amitriptyline Hcl | 88 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 88 | 16 |
| Finasteride | Finasteride | 86 | 13 |
| Bupropion Xl | Bupropion Hcl | 85 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 82 | 31 |
| Ibuprofen | Ibuprofen | 81 | 20 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 81 | 15 |
| Levofloxacin | Levofloxacin | 75 | 62 |
| Lovastatin | Lovastatin | 75 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 74 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 73 | 17 |
| Midodrine Hcl | Midodrine Hcl | 73 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 72 | 13 |
| Baclofen | Baclofen | 68 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 66 | 12 |
| Azithromycin | Azithromycin | 65 | 52 |
| Diclofenac Sodium | Diclofenac Sodium | 64 | 22 |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 63 | 11 |
| Linzess | Linaclotide | 63 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 63 | 43 |
| Ondansetron Hcl | Ondansetron Hcl | 63 | 21 |
| Nebivolol Hcl | Nebivolol Hcl | 62 | 12 |
| Ozempic | Semaglutide | 62 | 13 |
| Warfarin Sodium | Warfarin Sodium | 61 | 12 |
| Xarelto | Rivaroxaban | 61 | suppressed |
| Celecoxib | Celecoxib | 60 | 12 |
| Humalog Kwikpen U-100 | Insulin Lispro | 60 | 15 |
| Mupirocin | Mupirocin | 59 | 38 |
| Risperidone | Risperidone | 59 | suppressed |
| Sucralfate | Sucralfate | 59 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 59 | 11 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 58 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 57 | suppressed |
| Cephalexin | Cephalexin | 56 | 39 |
| Amiodarone Hcl | Amiodarone Hcl | 55 | 11 |
| Lorazepam | Lorazepam | 53 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 53 | 12 |
| Phenobarbital | Phenobarbital | 53 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 53 | suppressed |
| Estradiol | Estradiol | 52 | suppressed |
| Valsartan | Valsartan | 52 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 51 | 14 |
| Ondansetron Odt | Ondansetron | 49 | 16 |
| Cholestyramine | Cholestyramine (With Sugar) | 47 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 47 | 17 |
| Doxycycline Hyclate | Doxycycline Hyclate | 46 | 39 |
| Fluconazole | Fluconazole | 46 | 24 |
| Methocarbamol | Methocarbamol | 46 | suppressed |
| Aripiprazole | Aripiprazole | 45 | suppressed |
| Tradjenta | Linagliptin | 45 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 44 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 43 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 43 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 41 | suppressed |
| Diazepam | Diazepam | 40 | suppressed |
| Latanoprost | Latanoprost | 39 | suppressed |
| Trulicity | Dulaglutide | 39 | suppressed |
| Nitroglycerin | Nitroglycerin | 38 | 17 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 37 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 37 | 34 |
| Entresto | Sacubitril/Valsartan | 37 | suppressed |
| Amoxicillin | Amoxicillin | 35 | 31 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 34 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 33 | suppressed |
| Nystatin | Nystatin | 33 | 21 |
| Rivastigmine | Rivastigmine | 33 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 32 | suppressed |
| Letrozole | Letrozole | 32 | suppressed |
| Novolin R | Insulin Regular, Human | 32 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 32 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 31 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 31 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 31 | 28 |
| Glipizide | Glipizide | 31 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 31 | suppressed |
| Naproxen | Naproxen | 31 | suppressed |
| Olanzapine | Olanzapine | 31 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 31 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 31 | 11 |
| Vraylar | Cariprazine Hcl | 31 | suppressed |
| Haloperidol | Haloperidol | 30 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 30 | suppressed |
| Lactulose | Lactulose | 29 | 11 |
| Theophylline Er | Theophylline Anhydrous | 29 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 22 |
| Diltiazem Hcl | Diltiazem Hcl | 28 | suppressed |
| Humulin R | Insulin Regular, Human | 27 | suppressed |
| Novolog Flexpen | Insulin Aspart | 26 | suppressed |
| Amantadine | Amantadine Hcl | 25 | suppressed |
| Anastrozole | Anastrozole | 25 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 25 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 25 | 11 |
| Lidocaine | Lidocaine | 25 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 25 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 24 | suppressed |
| Methylprednisolone | Methylprednisolone | 24 | 14 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 24 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 23 | suppressed |
| Carbamazepine | Carbamazepine | 23 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 23 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 23 | 11 |
| Levetiracetam Er | Levetiracetam | 23 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 23 | 12 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 23 | 23 |
| Tresiba Flextouch U-100 | Insulin Degludec | 23 | suppressed |
| Metronidazole | Metronidazole | 22 | 13 |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 21 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 21 | suppressed |
| Carbidopa-Levodopa-Entacapone | Carbidopa/Levodopa/Entacapone | 21 | suppressed |
| Creon | Lipase/Protease/Amylase | 21 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 21 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 21 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 21 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 21 | suppressed |
| Sotalol | Sotalol Hcl | 21 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 20 | suppressed |
| Humalog | Insulin Lispro | 20 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 20 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 20 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 20 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 20 | suppressed |
| Xifaxan | Rifaximin | 20 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 19 | 19 |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 19 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 19 | suppressed |
| Rybelsus | Semaglutide | 19 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 19 | 16 |
| Glipizide Er | Glipizide | 18 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 18 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 18 | suppressed |
| Fentanyl | Fentanyl | 17 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 17 | suppressed |
| Synthroid | Levothyroxine Sodium | 17 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 16 | suppressed |
| Colchicine | Colchicine | 16 | suppressed |
| Dexamethasone | Dexamethasone | 16 | 15 |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 16 | suppressed |
| Methotrexate | Methotrexate Sodium | 16 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 16 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 16 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 15 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 15 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 15 | suppressed |
| Ofloxacin | Ofloxacin | 15 | 14 |
| Topiramate | Topiramate | 15 | suppressed |
| Torsemide | Torsemide | 15 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 14 | suppressed |
| Budesonide | Budesonide | 14 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 14 | suppressed |
| Chlorthalidone | Chlorthalidone | 14 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 14 | suppressed |
| Rexulti | Brexpiprazole | 14 | suppressed |
| Clotrimazole | Clotrimazole | 13 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 13 | suppressed |
| Premarin | Estrogens, Conjugated | 13 | suppressed |
| Temazepam | Temazepam | 13 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 12 | suppressed |
| Bumetanide | Bumetanide | 12 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 12 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Acetazolamide | Acetazolamide | 11 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 11 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Insulin Lispro | Insulin Lispro | 11 | suppressed |
| Klor-Con M20 | Potassium Chloride | 11 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 11 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 11 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 11 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $106.17 · 6 records | Insulet Corporation | GVOKE HYPOPEN, JOURNAVX, MOUNJARO, Ohtuvayre, Omnipod, QUTENZA, ZEPBOUND | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Mounjaro play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error